Value £1,400,000

Emerald

VC Funding

Pre-Seed

Healthcare & Biotech Published 29 January 2026

Summary

Emerald has secured a £1.4 million Pre-Seed investment led by Boost Capital Partners, bringing its total pre-seed funding to $2M (£1.4M).

Summary of transaction details:

Value: £1.4 million
Sector: Healthcare & Biotech
Advisor: Not disclosed
Key Entities: Emerald, Boost Capital Partners
Location: London, UK

Note: This investment marks a significant milestone in the preventive health revolution, and is expected to drive innovation and growth in the healthcare sector.

Lead Investor / Acquirer

Boost Capital Partners

Advising Broker

Undisclosed Firm

Related Deals in Healthcare & Biotech

Pre-Seed prioritised

VC Funding

Scan.com

£67,220,000

Sept 2026

VC Funding

Ternary Therapeutics

£3,600,000

Mar 2026

VC Funding

NuVision Biotherapies

£4,800,000

Mar 2026

VC Funding

Evaro

£18,000,000

Jan 2026

View Company Details

Financials, officers, full deal history

Original Source

View the original press release or news article describing this transaction in full.

Read Original Post

AI Insight Lenses

Pro

AI-generated analysis from four professional perspectives. Powered by PE Deals.

Free to all registered users.